Packaging Pharmacy Vaccine 
XTalks
OCTOBER 25, 2023
The US Food and Drug Administration (FDA) has accepted AstraZeneca’s supplemental biologics license application (sBLA) for a self-administered option of its nasal influenza vaccine FluMist Quadrivalent. FluMist has been in the market since 2003 and is the only intranasal spray vaccine option against flu.
World of DTC Marketing
APRIL 5, 2021
“Every day, I wonder if I’m going to call into my manager’s office and offered a package because I earn so much,” she told me. Pharmacy schools are turning out thousands of pharmacists who earn a lot less than pharmacists who have to work at hospitals for years. It’s happening in pharma as well.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
JANUARY 16, 2021
16, 2021 — President-elect Joe Biden described an ambitious national vaccination plan on Friday that will deliver coronavirus vaccines to far more people and invoke a wartime law to boost vaccine production. Even if Biden invokes the Korean War-era Defense Production Act, it may take some time to ease vaccine shortages.
Pharmaceutical Technology
JUNE 9, 2023
The drug performed “extraordinarily well” in a variety of cohorts, said Nimish Patel, PharmD, professor of clinical pharmacy at University of California San Diego. After a long period without any new approvals, in May, the FDA approved GSK’s vaccine Arexvy for the prevention of LRTD caused by RSV in individuals 60 and older.
FDA Law Blog
SEPTEMBER 30, 2024
Another rejected proposal was a definition of “vaccine” (vaccines are exempt from Medicaid rebates), which would have limited this term to a product that is administered prophylactically – i.e., to prevent rather than treat a disease. that is not supported by the statute and applicable regulations.”
The Pharma Data
JANUARY 12, 2021
“Tackling the COVID-19 pandemic will require a combination of public health measures, vaccines and therapeutics. . “COVID-19 continues to sicken hundreds of thousands of Americans every day and the people of Regeneron are committed to help,” said Leonard S. Schleifer , M.D., We are pleased to work with the U.S.
The Pharma Data
NOVEMBER 20, 2020
We are also very encouraged by recently announced promising vaccine results; however, there remains a need to treat patients who develop COVID-19, especially as some may not have had access to or were not protected by vaccination.
Expert insights. Personalized for you.
59 
Let's personalize your content